Related Experiment Video
Updated: Dec 28, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
The oncogenic role of hepatitis delta virus in hepatocellular carcinoma
Marc Puigvehí1,2, Carlos Moctezuma-Velázquez1, Augusto Villanueva1,3,4
1Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Abstract:
Hepatitis delta virus (HDV) is a small defective virus that needs hepatitis B virus (HBV) to replicate and propagate. HDV infection affects 20-40 million people worldwide and pegylated interferon (PegIFN) is the only recommended therapy. There is limited data on the contribution of HDV infection to HBV-related liver disease or liver cancer. Evidence from retrospective and cohort studies suggests that HBV/HDV coinfection accelerates progression to cirrhosis and is associated with an increased risk of hepatocellular carcinoma (HCC) development compared to HBV monoinfection. Although the life cycle of HDV is relatively well known, there is only ancillary information on the molecular mechanisms that can drive specific HDV-related oncogenesis. No thorough reports on the specific landscape of mutations or molecular classes of HDV-related HCC have been published. This information could be critical to better understand the uniqueness, if any, of HDV-related HCC and help identify novel targetable mutations. Herein, we review the evidence supporting an oncogenic role of HDV, the main reported mechanisms of HDV involvement and their impact on HCC development.
Insights
Hepatitis delta virus (HDV) coinfection with hepatitis B virus (HBV) accelerates liver disease progression and increases liver cancer risk. Further research is needed to understand HDV-specific oncogenesis and identify new therapeutic targets.
Area of Science:
- Hepatology
- Virology
- Oncology
Background:
- Hepatitis delta virus (HDV) is a defective virus requiring hepatitis B virus (HBV) for replication.
- HDV affects 20-40 million people globally, with pegylated interferon (PegIFN) as the sole recommended therapy.
- Limited data exists on HDV's role in HBV-related liver disease and cancer progression.
Purpose of the Study:
- To review evidence on the oncogenic role of HDV in hepatocellular carcinoma (HCC).
- To explore reported mechanisms of HDV involvement in HCC development.
- To highlight the need for understanding HDV-specific oncogenesis and potential therapeutic targets.
Main Methods:
- Literature review of retrospective and cohort studies.
- Analysis of existing evidence on HDV's contribution to liver disease and HCC.
- Synthesis of information on molecular mechanisms of HDV-related oncogenesis.
Main Results:
- HBV/HDV coinfection accelerates cirrhosis progression compared to HBV monoinfection.
- Coinfection is associated with an increased risk of developing HCC.
- Ancillary information exists on HDV's oncogenic mechanisms, but specific mutation landscapes are unreported.
Conclusions:
- HDV coinfection significantly impacts HBV-related liver disease severity and HCC risk.
- Understanding HDV-specific molecular mechanisms is crucial for characterizing HDV-related HCC.
- Further research into HDV-related oncogenesis may reveal novel therapeutic targets.
More Related Videos
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Abnormal Proliferation

